Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9358287
Method of treating stress hyperglycemia with human antibodies to the glucagon receptor
granted -
US 9353176
Method of treating osteoarthritis with an antibody to NGF
granted -
US 9353163
Apelin fusion proteins and uses thereof
granted -
US 9340594
VEGF antagonist formulations for intravitreal administration
granted -
US 9308256
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
granted -
US 9309326
Readily isolated bispecific antibodies with native immunoglobulin format
granted -
US 9302015
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
granted -
US 9301509
Genetically modified mice and engraftment
granted -
US 9290574
Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor
granted -
US 9284380
Anti-ErbB3 antibodies and uses thereof
granted -
US 9273143
Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody
granted -
US 9265827
Anti-PDGFR-beta antibodies and uses thereof
granted -
US 9260515
Antibodies to human GDF8
granted -
US 9254338
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 9238692
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 9228014
Antibodies capable of blocking the interaction between CD48 and a CD48 receptor
granted -
US 9193977
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 9193801
Stabilized formulations containing anti-PCSK9 antibodies
granted -
US 9173880
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted -
US 9150648
Anti-ASIC1 antibodies and uses thereof
granted -
US 9139644
Modified chimeric polypeptides with improved pharmacokinetic properties
granted -
US 9132192
Anti-EGFR antibodies and uses thereof
granted -
US 9127292
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 9127068
Nucleic acids encoding human glucagon receptor antibodies
granted